CClinicalTrials.gg
CompletedNCT01944501Updated Sep 17, 2013

Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss

An interventional study of Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation in Tinnitus and Hearing Loss, sponsored by University of Brasilia. Completed at 1 site in Brazil. Open to participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2013-09-17.

Sponsored by University of Brasilia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
All
01

Study summary

This study aimed at trying transcranial magnetic stimulation and transcranial direct current stimulation as potential treatments to decrease tinnitus in patients with significant hearing loss.

Read the detailed description

Tinnitus is a very common condition and affects approximately 15% of the population, disrupting sleep, emotional balance and social life of the patients. Acoustic deprivation causes hearing loss and is responsible for a cascade of processes that result in the reorganization of the cortex through a synchronization of neuronal activity related to a cortical re-mapping. Consistent with the hypothesis that tinnitus is caused by abnormal activation of the auditory cortex, repetitive transcranial magnetic stimulation (rTMS) can temporarily reduce cortical hyperactivity through direct neuromodulation of the temporal cortex. Furthermore, studies have shown that transcranial direct current stimulation (tDCS) can also suppress tinnitus. Objective: To determine the effectiveness of rTMS and TDCS in the treatment of patients with chronic tinnitus and auditory loss. Methods: We performed an analytical experimental double-blind study using rTMS and tDCS in patients with chronic tinnitus and hearing loss.

02

Conditions studied

  • Tinnitus
  • Hearing Loss

Keywords

  • tinnitus
  • hearing loss
  • Transcranial magnetic stimulation
  • Transcranial direct current stimulation
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 36 is close to the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

University of Brasilia is the lead sponsor of 63 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • chronic tinnitus
  • hearing loss

Exclusion criteria

Exclusion Criteria:

  • neurological diseases
  • use of drugs affecting the central nervous system
  • evidence of dementia
  • clinical diagnosis of depression
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
36 participants (actual)

Study arms

  • Active comparator
    Transcranial Magnetic Stimulation

    Patients receiving real transcranial magnetic stimulation

    Procedure: Transcranial Magnetic Stimulation

  • Placebo comparator
    Sham TMS

    Patients receiving sham transcranial magnetic stimulation

    Procedure: Transcranial Magnetic Stimulation

  • Active comparator
    Transcranial Direct Current Stimulation

    Patients receiving real transcranial direct current stimulation

    Procedure: Transcranial Direct Current Stimulation

  • Placebo comparator
    Sham TDCS

    Patients receiving sham transcranial direct current stimulation

    Procedure: Transcranial Direct Current Stimulation

Interventions

  • ProcedureTranscranial Magnetic Stimulation

    TMS over the left temporoparietal cortex

  • ProcedureTranscranial Direct Current Stimulation

    TDCS over the left temporoparietal cortex

06

What researchers measure

Primary outcomes

  1. Change in Tinnitus Handicap Inventory (THI) scores

    Time frame: THI was measured before intervention (baseline) and after 5 daily sessions (day 5)

Secondary outcomes

  1. Change in Visual Analog Scale scores

    Time frame: Visual analog scale of tinnitus was recorded at baseline and after daily 5 TMS or TDCS sessions ( day 5)

07

Study locations

1 site
  • Universidade de Brasília
    Brasília, Distrito Federal 70000, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01944501
Lead sponsor
University of Brasilia
Responsible party
Joaquim Brasil-Neto (Dr., University of Brasilia) — Principal investigator
First posted
Sep 17, 2013
Start date
Mar 2012
Primary completion
Dec 2012
Completion
Dec 2012
Last update
Sep 17, 2013

Study contacts

Joaquim P Brasil-Neto, PhD
principal investigator · University of Brasilia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion